IL‐22‐mediated renal metabolic reprogramming via PFKFB3 to treat kidney injury

Kidney damage initiates the deteriorating metabolic states in tubule cells that lead to the development of end‐stage renal disease (ESTD). Interleukin‐22 (IL‐22) is an effective therapeutic antidote for kidney injury via promoting kidney recovery, but little is known about the underlying molecular m...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wei, Shen, Yilan, Fan, Jiajun, Zeng, Xian, Zhang, Xuyao, Luan, Jingyun, Wang, Yichen, Zhang, Jinghui, Fang, Si, Mei, Xiaobin, Zhao, Zhen, Ju, Dianwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901723/
https://www.ncbi.nlm.nih.gov/pubmed/33634980
http://dx.doi.org/10.1002/ctm2.324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901723/
https://www.ncbi.nlm.nih.gov/pubmed/33634980
http://dx.doi.org/10.1002/ctm2.324

Ejemplares similares